Skip to main content
. 2018 Nov 17;18(4):283–293. doi: 10.1007/s40268-018-0255-7

Table 2.

Patient disposition by study and for the merged full analysis set

Status CONFIDENCE II
(N = 1253)
PROTECT I
(N = 988)
STH I
(N = 552)
STH II
(N = 379)
Merged FAS
(N = 3172)
Withdrawn, n (%) 35 (2.8) 24 (2.4) 0 (0.0) 22 (5.8) 81 (2.5)
 Withdrew consent 5 (0.4) 1 (0.1) 0 (0.0) 1 (0.3) 7 (0.2)
 Adverse event 23 (1.8) 17 (1.7) 0 (0.0) 17 (4.5) 57 (1.8)
 Lack of drug efficacy 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.03)
 Protocol violation 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.03)
 Non-compliance 1 (0.1) 2 (0.2) 0 (0.0) 1 (0.3) 4 (0.1)
 Other 4 (0.3) 4 (0.4) 0 (0.0) 3 (0.8) 11 (0.3)
Lost to follow up, n (%) 121 (9.7) 65 (6.6) 78 (14.1) 45 (11.8) 309 (9.7)
Completed, n (%) 1097 (87.5) 899 (91.0) 474 (85.9) 312 (82.3) 2782 (87.7)

FAS full analysis set, STH Shake the Habit